The search for disease-modifying drugs for neurodegenerative disorders

Author： Lenzken Silvia C Racchi Marco Lucchelli Adele Govoni Stefano

ISSN： 1479-6708

Source： Future Neurology, Vol.1, Iss.1, 2006-01, pp. : 87-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Towards Disease-Modifying Treatment of Alzheimer's Disease: Drugs Targeting &bgr; -Amyloid

Current Alzheimer Research, Vol. 7, Iss. 1, 2010-02 ,pp. : 40-55

Bentham Science Publishers

Access to resources Recommend Favorite

Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy

By Loscher W.

Epilepsy Research, Vol. 50, Iss. 1, 2002-06 ,pp. : 105-123

Elsevier

Access to resources Recommend Favorite

Metabolic Dysfunction in Alzheimer's Disease and Related Neurodegenerative Disorders

Current Alzheimer Research, Vol. 9, Iss. 1, 2012-01 ,pp. : 5-17

Bentham Science Publishers

Access to resources Recommend Favorite

M1 Agonists as a Potential Disease-Modifying Therapy for Alzheimer's Disease

Current Alzheimer Research, Vol. 6, Iss. 2, 2009-04 ,pp. : 112-117

Bentham Science Publishers

Access to resources Recommend Favorite

The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders

By Chung K.K.K. Dawson V.L. Dawson T.M.

Trends in Neurosciences, Vol. 24, Iss. 11, 2001-11 ,pp. : 7-14

Elsevier

Access to resources Recommend Favorite